New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed ...

Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...

clinical-challenge-respiratory-distress-CA0516 A congenital condition is found in an infant with respiratory and gastrointestinal symptoms. Lily, a 6-week-old infant, presents with difficulty ...

Infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves ...

Objective: The aim of the study was to measure pulmonary mechanics in infants with respiratory distress syndrome before extubation and to correlate pulmonary function values with successful extubation ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...

LA JOLLA, CA - Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin® (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant ...

The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant ...

A nine-month-old infant from Raipur in Chhattisgarh was successfully treated and saved after being airlifted to Hyderabad and undergoing 45 days of intensive care at KIMS Cuddles, Kondapur.